All Industry news articles – Page 6
-
Industry newsSemaglutide may help with PCOS and addiction disorders
Studies of diabetes and weight-loss drugs are underway to determine if they could also help manage a range of other conditions.
-
Industry newsBurkina Faso gives R21 malaria vaccine approval in children
Burkina Faso’s regulatory agency – Agence Nationale de la Regulation Pharmaceutique – has approved the R21/Matrix-M malaria vaccine for children.
-
Industry newsGlobal life sciences consultancy created from SSI/NDA merger
US-based SSI Strategy buys Sweden-based regulatory affairs consultancy NDA Group AB; Strömquist stays on as President of NDA unit.
-
Industry newsHuman COVID drug set to treat FCov-23 coronavirus in cats
A virulent strain of feline coronavirus has spread through Cyprus, and veterinarians on the island have received a first batch of anti-COVID pills.
-
Industry newsDevices sold on second-hand market retain sensitive data
Infusion pumps sold on secondary markets in the US were found to carry sensitive information about the hospitals that once owned them.
-
Industry newsRapid COVID-19 breath test device shows promise
A small, COVID-19 breath test device – developed by researchers from Washington University, St. Louis– can detect the SARS-CoV-2 virus.
-
Industry newsSafe use of AI is subject of EMA reflection paper
The EMA has published a draft paper on how artificial intelligence can support the development and use of human and veterinary medicines.
-
Industry newsPatient groups get pharma funding; often petition NICE
An investigation by The Observer reveals how patient groups receiving funding from pharma often petition NICE for NHS approvals.
-
Industry newsOff-label prescription of diabetes drug causes shortage
A spike in weight-related prescription of diabetes drug Ozempic has contributed to a national shortage, affecting those who need it.
-
Industry newsFDA's Emerging Technology Programme
The FDA’s Emerging Technology Programme intends to assist industry in gaining regulatory approval for innovative technology drug applications.
-
Industry newsFDA approves its first nonprescription birth control pill
FDA approves first over-the-counter (OTC) contraceptive pill for use in the US − it is expected to become the most effective OTC birth control.
-
Industry newsGood safety profile of COVID-19 vaccines declared by ICMRA
COVID-19 vaccines show a very good safety profile in all age groups, including people with underlying medical conditions and pregnancy.
-
Industry newsDementia patients retain ability to learn using devices: study
Dementia sufferers given iPad-like devices retain the ability to learn new things, and collaborate: Linköping University study.
-
Industry newsFDA approves radical design of pacemaker with no leads
A novel design of pacemaker – called Aveir DR – for use on two chambers of the heart without the need for wires, has been approved by the FDA.
-
Industry newsMHRA Corporate Plan supports access for patients to innovation
The MHRA’s Corporate Plan for 2023-26 seeks to set out how it will enable access to innovative medical products while ensuring patient safety.
-
Industry newsWellcome grants £5.7 million to combat MRSA
The Wellcome Trust’s Discovery Award has granted £5.7 million to a University of Sheffield team for research into antibiotic resistance.
-
Industry newsWearables can spot Parkinson’s up to seven years earlier
A smartwatch has been shown to be able to identify Parkinson’s disease up to seven years before symptoms appeared shows Cardiff University study.
-
Industry newsAI brings control of gene expression to CRISPR tech
CRISPR, the precision gene-editing technology, has been combined with artificial intelligence to control gene expression.
-
Industry newsAustralia moves to permit therapeutic use of psychedelics
The Therapeutic Goods Administration − Australia’s regulator − approves MDMA and psilocybin for treatment of PTSD and depression.
-
Industry newsAI-generated drug first to reach Phase II trials
Insilico Biotech’s INS018_055 – a drug generated by AI – is a treatment for a rare lung disease and the first AI drug to enter a Phase II trial.